NP-G2-044 Uses, Dosage, Side Effects and more
NP-G2-044 is under investigation in clinical trial NCT03199586 (Phase 1 Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Solid Tumors (Including Lymphoma)).
Trade Name | NP-G2-044 |
Generic | NP-G2-044 |
Type | |
Formula | C21H16F3N3O2 |
Weight | Average: 399.373 Monoisotopic: 399.119461256 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |